mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |